The Choice of Local Treatment Modalities for Patients with Brain Metastases from Digestive Cancers

Figure 2

Kaplan–Meier overall survival curves comparing patients receiving single therapy versus combination therapy for brain metastases. (a) All patients. (b) All patients with esophageal cancer. (c) All patients with gastric cancer. (d) All patients with liver cancer. (e) All patients with colorectum cancer (as the log rank test is not a proper statistical inference method for two crossing survival curves, we did landmark analyses discriminating between events occurring before and after 17 months). (f) Propensity score-matched patients.

(a)

(b)

(c)

(d)

(e)

(f)